Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
52.5 EUR | +0.96% | +2.97% | +41.30% |
Jul. 03 | Lonza Group Names New CEO | MT |
Jul. 02 | Lonza Group AG Announces CEO Changes | CI |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's high margin levels account for strong profits.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 42.86 and 34.14 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Biotechnology & Medical Research
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+41.30% | 42.06B | - | ||
+23.50% | 47.07B | B- | ||
-5.16% | 39.98B | B | ||
+36.37% | 33.02B | B | ||
-7.79% | 27.9B | C | ||
+18.06% | 27.63B | B- | ||
+47.29% | 14.37B | B+ | ||
+41.91% | 13.45B | C+ | ||
-1.02% | 12.03B | B+ | ||
-10.80% | 10.86B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LONN Stock
- LO3A Stock
- Ratings Lonza Group AG